epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Reglan

metoclopramide

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Tardive Dyskinesia

contraindicated in patients with tardive dyskinesia history; metoclopramide can cause tardive dyskinesia, a serious, potentially irreversible movement disorder; risk incr. with tx duration and total cumulative dosage; use shortest effective tx duration and periodically reassess need for tx; D/C immediately if patient develops tardive dyskinesia signs/symptoms; 12wk max tx duration for symptomatic, documented GERD; avoid >12wk tx for gastroparesis (if longer-term use unavoidable, then routinely monitor for tardive dyskinesia signs/symptoms)

Adult Dosing .

Dosage forms:  TAB: 5 mg, 10 mg

Dosage Form Details

[ODT, SOLUTION, INJ forms discontinued in US for this brand; see generic]

gastroparesis

[PO route]
Dose: 5-10 mg PO tid-qid; Max: 40 mg/day; 12wk; Info: start 5 mg PO qid in elderly patients; give 5 mg PO qid, max 20 mg/day in CYP2D6 poor metabolizers; give 30min before meals and at bedtime
[IM/IV route]
Dose: 10 mg IM/IV qid for up to 10 days; Max: 40 mg/day; 12 wk; Info: use lower doses in elderly patients; switch to PO when possible

GERD

[10-15 mg PO qid x4-12wk]
Max: 60 mg/day; 12wk; Alt: give up to 20 mg PO x1 prn before GERD-provoking situation; Info: for patients with concomitant gastroparesis; start 5 mg PO qid in elderly patients; give 5 mg PO qid or 10 mg PO tid, max 30 mg/day in CYP2D6 poor metabolizers; give 30min before meals and at bedtime

nausea/vomiting prevention, postop

[10-20 mg IM/IV x1]
Start: dose near end of procedure

small bowel intubation, post-pyloric placement

[10 mg IV x1 dose]

barium transit time acceleration, GI diagnostic studies

[10 mg IV x1 dose]

nausea/vomiting prevention, chemo-related

[highly-emetogenic chemo]
Dose: 2 mg/kg/dose IV q2h x3 doses, then 2 mg/kg/dose IV q3h x3 doses; Start: 30min before chemo; Info: may give 1 mg/kg/dose IV q2h x3 doses, then 1 mg/kg/dose IV q3h x3 doses for less emetogenic chemo
[low-emetogenic parenteral chemo (off-label)]
Dose: 10-20 mg PO/IV x1; Start: 30min before chemo; Info: may repeat 10-20 mg PO/IV qd for multi-day chemo; search 'CINV' for epocrates Chemo-Induced Nausea & Vomiting in Adults decision tool
[minimal- to low-emetogenic oral chemo (off-label)]
Dose: 10-20 mg PO x1 on day 1, then 10-20 mg PO q6h prn; Start: 30min before chemo; Info: search 'CINV' for epocrates Chemo-Induced Nausea & Vomiting in Adults decision tool

breakthrough nausea/vomiting, chemo-related (off-label)

[10-20 mg PO/IV q4-6h]
Info: search 'CINV' for epocrates Chemo-Induced Nausea & Vomiting in Adults decision tool

nausea/vomiting, migraine-associated (off-label)

[10-20 mg IV x1]
Alt: 5-10 mg PO/IM/IV q6-8h prn; Max: 45 mg/day

renal dosing

[gastroparesis, PO route]
CrCl <60: 5 mg qid, max 20 mg/day; ESRD: 5 mg bid, max 10 mg/day
HD: 5 mg bid, max 10 mg/day; no supplement after dialysis; PD: 5 mg bid, max 10 mg/day; no supplement
[GERD]
CrCl <60: 5 mg qid or 10 mg tid, max 30 mg/day; ESRD: 5 mg qid or 10 mg bid, max 20 mg/day
HD: 5 mg qid or 10 mg bid, max 20 mg/day; no supplement after dialysis; PD: 5 mg qid or 10 mg bid, max 20 mg/day; no supplement
[all other indications]
CrCl <60: decr. usual dose by 50%; ESRD: decr. usual dose by 75%
HD: decr. usual dose by 75%; no supplement after dialysis; PD: decr. usual dose by 75%; no supplement

hepatic dosing

[gastroparesis, PO route]
Child-Pugh Class B or C: 5 mg qid, max 20 mg/day
[GERD]
Child-Pugh Class B or C: 5 mg qid or 10 mg tid, max 30 mg/day
[all other indications]
Child-Pugh Class B or C: decr. usual dose by 50%

Peds Dosing .

Dosage forms:  TAB: 5 mg, 10 mg

Dosage Form Details

[ODT, SOLUTION, INJ forms discontinued in US for this brand; see generic]

small bowel intubation, post-pyloric placement

[<6 yo]
Dose: 0.1 mg/kg/dose IV x1
[6-14 yo]
Dose: 2.5-5 mg IV x1
[>14 yo]
Dose: 10 mg IV x1

GERD (off-label)

[0.1-0.2 mg/kg/dose PO qid]
Max: 10 mg/dose, 0.8 mg/kg/24h; 12wk; Info: not recommended for infants and children per NASPGHAN/ESPGHAN guidelines; give 30min before meals and at bedtime

nausea/vomiting prevention, chemo-related (off-label)

[1-2 mg/kg/dose IV q2-4h]
Info: give 30min before chemo; pretreat with diphenhydramine to decr. EPS; not 1st-line agent

nausea/vomiting prevention, postop (off-label)

[0.1-0.2 mg/kg/dose IV x1]
Start: dose near end of procedure; Max: 10 mg/dose

nausea/vomiting, migraine-associated (off-label)

[2 yo and older]
Dose: 0.2 mg/kg/dose IV x1; Max: 10 mg/dose

renal dosing

[adjust dose amount]
CrCl <60: decr. usual dose by 50%; ESRD: decr. usual dose by 75%
HD: decr. usual dose by 75%; no supplement after dialysis; PD: decr. usual dose by 75%; no supplement

hepatic dosing

[adjust dose amount]
Child-Pugh Class B or C: decr. usual dose by 50%

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@15b23680
  • hypersensitivity to drug or ingredient
  • tardive dyskinesia history
  • dystonic reaction history, metoclopramide-associated
  • GI bleeding
  • GI perforation
  • GI obstruction
  • pheochromocytoma
  • paraganglioma, catecholamine-releasing
  • HTN
  • seizure disorder
  • depression
  • Parkinson disease
  • caution: hypersensitivity to tartrazine (some generic forms)
  • caution: CNS depressant use, concurrent
  • caution: alcohol use, concurrent
  • caution: CYP2D6 poor metabolizers
  • caution: neonates
  • caution: peds patients
  • caution: elderly patients
  • caution: CrCl <60
  • caution: hepatic impairment, Child-Pugh Class B-C
  • caution: cirrhosis
  • caution: CHF
  • caution: diabetes mellitus
  • caution: NADH methemoglobin reductase deficiency

Drug Interactions .

Overview

metoclopramide

dopamine-2 antagonist; prokinetic

Interaction Characteristics:
  • CYP2D6 substrate
  • CYP3A4 substrate
  • affected by altered gastrointestinal motility
  • CNS depression
  • dopamine antagonist
  • extrapyramidal effects
  • hyperprolactinemic effects
  • hypertensive effects
  • increases gastrointestinal motility
  • lowers seizure threshold
  • methemoglobinemia
  • serotonergic effects

Contraindicated

  • lidocaine topical
  • Reglan (metoclopramide)
    +
    lidocaine topical
    1 interaction

    Contraindicated

    metoclopramide + lidocaine topical

    contraindicated if <1 yo; otherwise, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of methemoglobinemia (additive effects)

  • prilocaine topical
  • Reglan (metoclopramide)
    +
    prilocaine topical
    1 interaction

    Contraindicated

    metoclopramide + prilocaine topical

    contraindicated if <1 yo; otherwise, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of methemoglobinemia (additive effects)

Avoid/Use Alternative

  • 5-HTP
  • Reglan (metoclopramide)
    +
    5-HTP
    1 interaction

    Avoid/Use Alternative

    metoclopramide + 5-HTP

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • aldesleukin
  • Reglan (metoclopramide)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + aldesleukin

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, seizures (additive effects)

  • alfentanil
  • Reglan (metoclopramide)
    +
    alfentanil
    1 interaction

    Avoid/Use Alternative

    metoclopramide + alfentanil

    use alternative or monitor BP, respiratory rate, serotonin syndrome sx, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • allopurinol
  • Reglan (metoclopramide)
    +
    allopurinol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + allopurinol

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • almotriptan
  • Reglan (metoclopramide)
    +
    almotriptan
    1 interaction

    Avoid/Use Alternative

    metoclopramide + almotriptan

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • alprazolam
  • Reglan (metoclopramide)
    +
    alprazolam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + alprazolam

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • amantadine
  • Reglan (metoclopramide)
    +
    amantadine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + amantadine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • amifampridine
  • Reglan (metoclopramide)
    +
    amifampridine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + amifampridine

    consider alternative: combo may incr. risk of seizures (additive effects)

  • amitriptyline
  • Reglan (metoclopramide)
    +
    amitriptyline
    1 interaction

    Avoid/Use Alternative

    metoclopramide + amitriptyline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • amoxapine
  • Reglan (metoclopramide)
    +
    amoxapine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + amoxapine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • amphetamine
  • Reglan (metoclopramide)
    +
    amphetamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + amphetamine

    consider alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration; decr. amphetamine start dose: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • apomorphine
  • Reglan (metoclopramide)
    +
    apomorphine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + apomorphine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • apraclonidine ophthalmic
  • Reglan (metoclopramide)
    +
    apraclonidine ophthalmic
    1 interaction

    Avoid/Use Alternative

    metoclopramide + apraclonidine ophthalmic

    use alternative if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • aripiprazole bimonthly injection
  • Reglan (metoclopramide)
    +
    aripiprazole bimonthly injection
    1 interaction

    Avoid/Use Alternative

    metoclopramide + aripiprazole bimonthly injection

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • aripiprazole lauroxil
  • Reglan (metoclopramide)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    metoclopramide + aripiprazole lauroxil

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • aripiprazole monthly injection
  • Reglan (metoclopramide)
    +
    aripiprazole monthly injection
    1 interaction

    Avoid/Use Alternative

    metoclopramide + aripiprazole monthly injection

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • aripiprazole oral
  • Reglan (metoclopramide)
    +
    aripiprazole oral
    1 interaction

    Avoid/Use Alternative

    metoclopramide + aripiprazole oral

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • asenapine
  • Reglan (metoclopramide)
    +
    asenapine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + asenapine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • atovaquone
  • Reglan (metoclopramide)
    +
    atovaquone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + atovaquone

    use alternative: combo may decr. atovaquone levels, efficacy (absorption decreased)

  • baclofen
  • Reglan (metoclopramide)
    +
    baclofen
    1 interaction

    Avoid/Use Alternative

    metoclopramide + baclofen

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • baclofen intrathecal
  • Reglan (metoclopramide)
    +
    baclofen intrathecal
    1 interaction

    Avoid/Use Alternative

    metoclopramide + baclofen intrathecal

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • brexpiprazole
  • Reglan (metoclopramide)
    +
    brexpiprazole
    1 interaction

    Avoid/Use Alternative

    metoclopramide + brexpiprazole

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • brimonidine ophthalmic
  • Reglan (metoclopramide)
    +
    brimonidine ophthalmic
    1 interaction

    Avoid/Use Alternative

    metoclopramide + brimonidine ophthalmic

    use alternative if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

  • brimonidine topical
  • Reglan (metoclopramide)
    +
    brimonidine topical
    1 interaction

    Avoid/Use Alternative

    metoclopramide + brimonidine topical

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • brivaracetam
  • Reglan (metoclopramide)
    +
    brivaracetam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + brivaracetam

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • bromocriptine
  • Reglan (metoclopramide)
    +
    bromocriptine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + bromocriptine

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • brompheniramine
  • Reglan (metoclopramide)
    +
    brompheniramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + brompheniramine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • buprenorphine
  • Reglan (metoclopramide)
    +
    buprenorphine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + buprenorphine

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • bupropion
  • Reglan (metoclopramide)
    +
    bupropion
    1 interaction

    Avoid/Use Alternative

    metoclopramide + bupropion

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: monitor BP; decr. metoclopramide dose, consider lower bupropion doses: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, HTN, seizures, other adverse effects (hepatic metabolism inhibited, additive effects)

  • buspirone
  • Reglan (metoclopramide)
    +
    buspirone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + buspirone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • butalbital
  • Reglan (metoclopramide)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    metoclopramide + butalbital

    use alternative or monitor respiratory rate: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • butorphanol
  • Reglan (metoclopramide)
    +
    butorphanol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + butorphanol

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • cabergoline
  • Reglan (metoclopramide)
    +
    cabergoline
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cabergoline

    avoid combo: combo may decr. efficacy of both drugs (antagonistic effects)

  • cannabidiol
  • Reglan (metoclopramide)
    +
    cannabidiol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cannabidiol

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • cannabis
  • Reglan (metoclopramide)
    +
    cannabis
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cannabis

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, HTN (additive effects)

  • carbamazepine
  • Reglan (metoclopramide)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + carbamazepine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration; consider decr. dose of one or both drugs: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, metoclopramide may decrease seizure threshold)

  • carbinoxamine
  • Reglan (metoclopramide)
    +
    carbinoxamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + carbinoxamine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • cariprazine
  • Reglan (metoclopramide)
    +
    cariprazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cariprazine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • carisoprodol
  • Reglan (metoclopramide)
    +
    carisoprodol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + carisoprodol

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cenobamate
  • Reglan (metoclopramide)
    +
    cenobamate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cenobamate

    use alternative: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • cetirizine
  • Reglan (metoclopramide)
    +
    cetirizine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cetirizine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chamomile, German
  • Reglan (metoclopramide)
    +
    chamomile, German
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chamomile, German

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chasteberry
  • Reglan (metoclopramide)
    +
    chasteberry
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chasteberry

    avoid combo: combo may decr. metoclopramide efficacy (antagonistic effects, chasteberry exerts dopaminergic effects)

  • chlophedianol
  • Reglan (metoclopramide)
    +
    chlophedianol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chlophedianol

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • chlorcyclizine
  • Reglan (metoclopramide)
    +
    chlorcyclizine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chlorcyclizine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • chlordiazepoxide
  • Reglan (metoclopramide)
    +
    chlordiazepoxide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chlordiazepoxide

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • chloroquine
  • Reglan (metoclopramide)
    +
    chloroquine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chloroquine

    avoid combo: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • chlorpheniramine
  • Reglan (metoclopramide)
    +
    chlorpheniramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chlorpheniramine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • chlorpromazine
  • Reglan (metoclopramide)
    +
    chlorpromazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chlorpromazine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • chlorzoxazone
  • Reglan (metoclopramide)
    +
    chlorzoxazone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + chlorzoxazone

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • citalopram
  • Reglan (metoclopramide)
    +
    citalopram
    1 interaction

    Avoid/Use Alternative

    metoclopramide + citalopram

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome (additive effects)

  • clemastine
  • Reglan (metoclopramide)
    +
    clemastine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + clemastine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • clobazam
  • Reglan (metoclopramide)
    +
    clobazam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + clobazam

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • clomipramine
  • Reglan (metoclopramide)
    +
    clomipramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + clomipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, seizures, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • clonazepam
  • Reglan (metoclopramide)
    +
    clonazepam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + clonazepam

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • clonidine
  • Reglan (metoclopramide)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + clonidine

    if ADHD use, avoid combo; otherwise, use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • clorazepate
  • Reglan (metoclopramide)
    +
    clorazepate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + clorazepate

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • clozapine
  • Reglan (metoclopramide)
    +
    clozapine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + clozapine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, seizures, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • codeine
  • Reglan (metoclopramide)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + codeine

    avoid combo if antitussive use; otherwise, use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • cyclobenzaprine
  • Reglan (metoclopramide)
    +
    cyclobenzaprine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cyclobenzaprine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • cyproheptadine
  • Reglan (metoclopramide)
    +
    cyproheptadine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + cyproheptadine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • dacomitinib
  • Reglan (metoclopramide)
    +
    dacomitinib
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dacomitinib

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: decr. metoclopramide dose: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, other adverse effects (hepatic metabolism inhibited)

  • dantrolene
  • Reglan (metoclopramide)
    +
    dantrolene
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dantrolene

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • daridorexant
  • Reglan (metoclopramide)
    +
    daridorexant
    1 interaction

    Avoid/Use Alternative

    metoclopramide + daridorexant

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • darifenacin
  • Reglan (metoclopramide)
    +
    darifenacin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + darifenacin

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • desflurane
  • Reglan (metoclopramide)
    +
    desflurane
    1 interaction

    Avoid/Use Alternative

    metoclopramide + desflurane

    use alternative or monitor respiratory rate, consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • desipramine
  • Reglan (metoclopramide)
    +
    desipramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + desipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • desvenlafaxine
  • Reglan (metoclopramide)
    +
    desvenlafaxine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + desvenlafaxine

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome, HTN, dystonia (additive effects)

  • deutetrabenazine
  • Reglan (metoclopramide)
    +
    deutetrabenazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + deutetrabenazine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dexbrompheniramine
  • Reglan (metoclopramide)
    +
    dexbrompheniramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dexbrompheniramine

    use alternative: combo may decr. metoclopramide efficacy; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying; additive effects)

  • dexchlorpheniramine
  • Reglan (metoclopramide)
    +
    dexchlorpheniramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dexchlorpheniramine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • dexmedetomidine
  • Reglan (metoclopramide)
    +
    dexmedetomidine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dexmedetomidine

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dexmedetomidine injection
  • Reglan (metoclopramide)
    +
    dexmedetomidine injection
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dexmedetomidine injection

    use alternative or monitor respiratory rate, consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • dextroamphetamine
  • Reglan (metoclopramide)
    +
    dextroamphetamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dextroamphetamine

    consider alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration; decr. dextroamphetamine start dose: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • diazepam
  • Reglan (metoclopramide)
    +
    diazepam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + diazepam

    use alternative or monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may alter seizure control; may incr. risk of profound CNS and respiratory depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • dichlorphenamide
  • Reglan (metoclopramide)
    +
    dichlorphenamide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dichlorphenamide

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • difelikefalin
  • Reglan (metoclopramide)
    +
    difelikefalin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + difelikefalin

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • difenoxin
  • Reglan (metoclopramide)
    +
    difenoxin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + difenoxin

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. efficacy of both drugs (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • dihydrocodeine
  • Reglan (metoclopramide)
    +
    dihydrocodeine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dihydrocodeine

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • dimenhydrinate
  • Reglan (metoclopramide)
    +
    dimenhydrinate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dimenhydrinate

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • diphenhydramine
  • Reglan (metoclopramide)
    +
    diphenhydramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + diphenhydramine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • diphenoxylate
  • Reglan (metoclopramide)
    +
    diphenoxylate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + diphenoxylate

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. efficacy of both drugs (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • domperidone
  • Reglan (metoclopramide)
    +
    domperidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + domperidone

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • doxepin
  • Reglan (metoclopramide)
    +
    doxepin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + doxepin

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • doxepin topical
  • Reglan (metoclopramide)
    +
    doxepin topical
    1 interaction

    Avoid/Use Alternative

    metoclopramide + doxepin topical

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • doxylamine
  • Reglan (metoclopramide)
    +
    doxylamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + doxylamine

    avoid combo if doxylamine use for pregnancy-related nausea/vomiting, otherwise, use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • dronabinol
  • Reglan (metoclopramide)
    +
    dronabinol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + dronabinol

    use alternative or monitor BP, HR: combo may incr. risk of CNS depression, psychomotor impairment, HTN, tachycardia (additive effects)

  • droperidol
  • Reglan (metoclopramide)
    +
    droperidol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + droperidol

    use alternative or decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • duloxetine
  • Reglan (metoclopramide)
    +
    duloxetine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + duloxetine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome (additive effects)

  • efavirenz
  • Reglan (metoclopramide)
    +
    efavirenz
    1 interaction

    Avoid/Use Alternative

    metoclopramide + efavirenz

    use alternative: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • eletriptan
  • Reglan (metoclopramide)
    +
    eletriptan
    1 interaction

    Avoid/Use Alternative

    metoclopramide + eletriptan

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • elinzanetant
  • Reglan (metoclopramide)
    +
    elinzanetant
    1 interaction

    Avoid/Use Alternative

    metoclopramide + elinzanetant

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • entacapone
  • Reglan (metoclopramide)
    +
    entacapone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + entacapone

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • entrectinib
  • Reglan (metoclopramide)
    +
    entrectinib
    1 interaction

    Avoid/Use Alternative

    metoclopramide + entrectinib

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • epinephrine inhaled
  • Reglan (metoclopramide)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    metoclopramide + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • escitalopram
  • Reglan (metoclopramide)
    +
    escitalopram
    1 interaction

    Avoid/Use Alternative

    metoclopramide + escitalopram

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome (additive effects)

  • esketamine
  • Reglan (metoclopramide)
    +
    esketamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + esketamine

    use alternative or monitor BP, respiratory rate: combo may incr. risk of HTN, CNS and respiratory depression, psychomotor impairment (additive effects)

  • eslicarbazepine acetate
  • Reglan (metoclopramide)
    +
    eslicarbazepine acetate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + eslicarbazepine acetate

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • estazolam
  • Reglan (metoclopramide)
    +
    estazolam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + estazolam

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • eszopiclone
  • Reglan (metoclopramide)
    +
    eszopiclone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + eszopiclone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ethanol (alcoholic beverage)
  • Reglan (metoclopramide)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ethanol (alcoholic beverage)

    avoid combo: combo may incr. ethanol levels, risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension (acute alcohol use), HTN (chronic alcohol use), other adverse effects (absorption increased, additive effects)

  • ethanol (in some formulations)
  • Reglan (metoclopramide)
    +
    ethanol (in some formulations)
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ethanol (in some formulations)

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • ethanol injection
  • Reglan (metoclopramide)
    +
    ethanol injection
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ethanol injection

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • ethosuximide
  • Reglan (metoclopramide)
    +
    ethosuximide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ethosuximide

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • etomidate
  • Reglan (metoclopramide)
    +
    etomidate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + etomidate

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • felbamate
  • Reglan (metoclopramide)
    +
    felbamate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + felbamate

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • fenfluramine
  • Reglan (metoclopramide)
    +
    fenfluramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + fenfluramine

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may alter seizure control; may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN, including hypertensive crisis (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • fentanyl
  • Reglan (metoclopramide)
    +
    fentanyl
    1 interaction

    Avoid/Use Alternative

    metoclopramide + fentanyl

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • fesoterodine
  • Reglan (metoclopramide)
    +
    fesoterodine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + fesoterodine

    use alternative: combo may decr. metoclopramide efficacy; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying; additive effects)

  • flibanserin
  • Reglan (metoclopramide)
    +
    flibanserin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + flibanserin

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • fluoxetine
  • Reglan (metoclopramide)
    +
    fluoxetine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + fluoxetine

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration; decr. metoclopramide dose: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, CNS depression, psychomotor impairment, serotonin syndrome, other adverse effects (hepatic metabolism inhibited, additive effects)

  • fluphenazine
  • Reglan (metoclopramide)
    +
    fluphenazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + fluphenazine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • flurazepam
  • Reglan (metoclopramide)
    +
    flurazepam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + flurazepam

    use alternative or monitor respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • fluvoxamine
  • Reglan (metoclopramide)
    +
    fluvoxamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + fluvoxamine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome (additive effects)

  • foslevodopa
  • Reglan (metoclopramide)
    +
    foslevodopa
    1 interaction

    Avoid/Use Alternative

    metoclopramide + foslevodopa

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • fosphenytoin
  • Reglan (metoclopramide)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + fosphenytoin

    use alternative: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • frovatriptan
  • Reglan (metoclopramide)
    +
    frovatriptan
    1 interaction

    Avoid/Use Alternative

    metoclopramide + frovatriptan

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • furosemide
  • Reglan (metoclopramide)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + furosemide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • gabapentin
  • Reglan (metoclopramide)
    +
    gabapentin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + gabapentin

    use alternative or monitor respiratory rate; consider decreasing gabapentin dose: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decrease seizure threshold)

  • gabapentin enacarbil
  • Reglan (metoclopramide)
    +
    gabapentin enacarbil
    1 interaction

    Avoid/Use Alternative

    metoclopramide + gabapentin enacarbil

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • galantamine
  • Reglan (metoclopramide)
    +
    galantamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + galantamine

    avoid combo: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • ganaxolone
  • Reglan (metoclopramide)
    +
    ganaxolone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ganaxolone

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • gepirone
  • Reglan (metoclopramide)
    +
    gepirone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + gepirone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • glofitamab
  • Reglan (metoclopramide)
    +
    glofitamab
    1 interaction

    Avoid/Use Alternative

    metoclopramide + glofitamab

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • glycopyrrolate
  • Reglan (metoclopramide)
    +
    glycopyrrolate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + glycopyrrolate

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • granisetron
  • Reglan (metoclopramide)
    +
    granisetron
    1 interaction

    Avoid/Use Alternative

    metoclopramide + granisetron

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • guanfacine
  • Reglan (metoclopramide)
    +
    guanfacine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + guanfacine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • haloperidol
  • Reglan (metoclopramide)
    +
    haloperidol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + haloperidol

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • hydrocodone
  • Reglan (metoclopramide)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + hydrocodone

    avoid combo if antitussive use; otherwise, use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • hydromorphone
  • Reglan (metoclopramide)
    +
    hydromorphone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + hydromorphone

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • hydroxyzine
  • Reglan (metoclopramide)
    +
    hydroxyzine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + hydroxyzine

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • hyoscyamine
  • Reglan (metoclopramide)
    +
    hyoscyamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + hyoscyamine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • ifosfamide
  • Reglan (metoclopramide)
    +
    ifosfamide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ifosfamide

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • iloperidone
  • Reglan (metoclopramide)
    +
    iloperidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + iloperidone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • imipramine
  • Reglan (metoclopramide)
    +
    imipramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + imipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • iohexol
  • Reglan (metoclopramide)
    +
    iohexol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + iohexol

    avoid combo if intrathecal iohexol use: combo may incr. risk of seizures (additive effects)

  • isocarboxazid
  • Reglan (metoclopramide)
    +
    isocarboxazid
    1 interaction

    Avoid/Use Alternative

    metoclopramide + isocarboxazid

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN (additive effects)

  • isoflurane
  • Reglan (metoclopramide)
    +
    isoflurane
    1 interaction

    Avoid/Use Alternative

    metoclopramide + isoflurane

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • isoniazid
  • Reglan (metoclopramide)
    +
    isoniazid
    1 interaction

    Avoid/Use Alternative

    metoclopramide + isoniazid

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, isoniazid inhibits monoamine oxidase)

  • kava
  • Reglan (metoclopramide)
    +
    kava
    1 interaction

    Avoid/Use Alternative

    metoclopramide + kava

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • ketamine
  • Reglan (metoclopramide)
    +
    ketamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ketamine

    use alternative or monitor respiratory rate, BP; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression (including life-threatening), psychomotor impairment, HTN, other sympathomimetic adverse effects (additive effects)

  • kratom
  • Reglan (metoclopramide)
    +
    kratom
    1 interaction

    Avoid/Use Alternative

    metoclopramide + kratom

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • lacosamide
  • Reglan (metoclopramide)
    +
    lacosamide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lacosamide

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • lamotrigine
  • Reglan (metoclopramide)
    +
    lamotrigine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lamotrigine

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • lemborexant
  • Reglan (metoclopramide)
    +
    lemborexant
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lemborexant

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levetiracetam
  • Reglan (metoclopramide)
    +
    levetiracetam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + levetiracetam

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • levocetirizine
  • Reglan (metoclopramide)
    +
    levocetirizine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + levocetirizine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levodopa
  • Reglan (metoclopramide)
    +
    levodopa
    1 interaction

    Avoid/Use Alternative

    metoclopramide + levodopa

    avoid combo: combo may decr. efficacy of both drugs; may incr. levodopa bioavailability, risk of CNS depression, psychomotor impairment, other adverse effects (antagonistic effects; absorption increased, additive effects)

  • levomilnacipran
  • Reglan (metoclopramide)
    +
    levomilnacipran
    1 interaction

    Avoid/Use Alternative

    metoclopramide + levomilnacipran

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • levorphanol
  • Reglan (metoclopramide)
    +
    levorphanol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + levorphanol

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • linezolid
  • Reglan (metoclopramide)
    +
    linezolid
    1 interaction

    Avoid/Use Alternative

    metoclopramide + linezolid

    use alternative or hold metoclopramide if urgent use; monitor BP, serotonin syndrome sx x2wk after metoclopramide D/C or 24h after last linezolid dose: combo may incr. risk of serotonin syndrome, HTN (additive effects, linezolid reversibly inhibits monoamine oxidase)

  • linvoseltamab
  • Reglan (metoclopramide)
    +
    linvoseltamab
    1 interaction

    Avoid/Use Alternative

    metoclopramide + linvoseltamab

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lisdexamfetamine
  • Reglan (metoclopramide)
    +
    lisdexamfetamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lisdexamfetamine

    consider alternative or monitor BP, serotonin syndrome symptoms, especially during initiation/titration; decr. lisdexamfetamine start dose: combo may incr. risk of serotonin syndrome, HTN (additive effects)

  • lithium
  • Reglan (metoclopramide)
    +
    lithium
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lithium

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • lofexidine
  • Reglan (metoclopramide)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lofexidine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lorazepam
  • Reglan (metoclopramide)
    +
    lorazepam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lorazepam

    use alternative or monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may alter seizure control; may incr. risk of profound CNS and respiratory depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • loxapine
  • Reglan (metoclopramide)
    +
    loxapine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + loxapine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • lumateperone
  • Reglan (metoclopramide)
    +
    lumateperone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lumateperone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • lurasidone
  • Reglan (metoclopramide)
    +
    lurasidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + lurasidone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • mavorixafor
  • Reglan (metoclopramide)
    +
    mavorixafor
    1 interaction

    Avoid/Use Alternative

    metoclopramide + mavorixafor

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: decr. metoclopramide dose: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, other adverse effects (hepatic metabolism inhibited)

  • meclizine
  • Reglan (metoclopramide)
    +
    meclizine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + meclizine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • melatonin
  • Reglan (metoclopramide)
    +
    melatonin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + melatonin

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • meperidine
  • Reglan (metoclopramide)
    +
    meperidine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + meperidine

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • meprobamate
  • Reglan (metoclopramide)
    +
    meprobamate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + meprobamate

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metaxalone
  • Reglan (metoclopramide)
    +
    metaxalone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + metaxalone

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, serotonin syndrome (additive effects)

  • methadone
  • Reglan (metoclopramide)
    +
    methadone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + methadone

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • methamphetamine
  • Reglan (metoclopramide)
    +
    methamphetamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + methamphetamine

    consider alternative or monitor BP, serotonin syndrome symptoms, especially during initiation/titration; decr. methamphetamine start dose: combo may incr. risk of serotonin syndrome, HTN (additive effects)

  • methocarbamol
  • Reglan (metoclopramide)
    +
    methocarbamol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + methocarbamol

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methohexital
  • Reglan (metoclopramide)
    +
    methohexital
    1 interaction

    Avoid/Use Alternative

    metoclopramide + methohexital

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • methsuximide
  • Reglan (metoclopramide)
    +
    methsuximide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + methsuximide

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • methyldopa
  • Reglan (metoclopramide)
    +
    methyldopa
    1 interaction

    Avoid/Use Alternative

    metoclopramide + methyldopa

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • methylene blue oral
  • Reglan (metoclopramide)
    +
    methylene blue oral
    1 interaction

    Avoid/Use Alternative

    metoclopramide + methylene blue oral

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • metyrapone
  • Reglan (metoclopramide)
    +
    metyrapone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + metyrapone

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metyrosine
  • Reglan (metoclopramide)
    +
    metyrosine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + metyrosine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • midazolam
  • Reglan (metoclopramide)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + midazolam

    use alternative or monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may alter seizure control; may incr. risk of profound CNS and respiratory depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • midodrine
  • Reglan (metoclopramide)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • milnacipran
  • Reglan (metoclopramide)
    +
    milnacipran
    1 interaction

    Avoid/Use Alternative

    metoclopramide + milnacipran

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome, HTN, dystonia (additive effects)

  • milsaperidone
  • Reglan (metoclopramide)
    +
    milsaperidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + milsaperidone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • mirtazapine
  • Reglan (metoclopramide)
    +
    mirtazapine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + mirtazapine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration; consider decr. dose of one or both drugs: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • mitotane
  • Reglan (metoclopramide)
    +
    mitotane
    1 interaction

    Avoid/Use Alternative

    metoclopramide + mitotane

    use alternative: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • molindone
  • Reglan (metoclopramide)
    +
    molindone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + molindone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • morphine
  • Reglan (metoclopramide)
    +
    morphine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + morphine

    use alternative or monitor respiratory rate, serotonin syndrome sx, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • mosunetuzumab
  • Reglan (metoclopramide)
    +
    mosunetuzumab
    1 interaction

    Avoid/Use Alternative

    metoclopramide + mosunetuzumab

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mycophenolate mofetil
  • Reglan (metoclopramide)
    +
    mycophenolate mofetil
    1 interaction

    Avoid/Use Alternative

    metoclopramide + mycophenolate mofetil

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nalbuphine
  • Reglan (metoclopramide)
    +
    nalbuphine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + nalbuphine

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • naltrexone
  • Reglan (metoclopramide)
    +
    naltrexone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + naltrexone

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naratriptan
  • Reglan (metoclopramide)
    +
    naratriptan
    1 interaction

    Avoid/Use Alternative

    metoclopramide + naratriptan

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • nefazodone
  • Reglan (metoclopramide)
    +
    nefazodone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + nefazodone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • nelarabine
  • Reglan (metoclopramide)
    +
    nelarabine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + nelarabine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nortriptyline
  • Reglan (metoclopramide)
    +
    nortriptyline
    1 interaction

    Avoid/Use Alternative

    metoclopramide + nortriptyline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • olanzapine
  • Reglan (metoclopramide)
    +
    olanzapine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + olanzapine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis), neuroleptic malignant syndrome, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • oliceridine
  • Reglan (metoclopramide)
    +
    oliceridine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + oliceridine

    use alternative or monitor respiratory rate, BP, serotonin syndrome sx, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • ondansetron
  • Reglan (metoclopramide)
    +
    ondansetron
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ondansetron

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • opicapone
  • Reglan (metoclopramide)
    +
    opicapone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + opicapone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • opium
  • Reglan (metoclopramide)
    +
    opium
    1 interaction

    Avoid/Use Alternative

    metoclopramide + opium

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • orphenadrine
  • Reglan (metoclopramide)
    +
    orphenadrine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + orphenadrine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • oxazepam
  • Reglan (metoclopramide)
    +
    oxazepam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + oxazepam

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • oxcarbazepine
  • Reglan (metoclopramide)
    +
    oxcarbazepine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + oxcarbazepine

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • oxybate
  • Reglan (metoclopramide)
    +
    oxybate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + oxybate

    use alternative or monitor respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, syncope (additive effects)

  • oxybutynin
  • Reglan (metoclopramide)
    +
    oxybutynin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + oxybutynin

    use alternative or decr. dose of one or both drugs or consider oxybutynin transdermal patch: combo may incr. risk of CNS depression, psychomotor impairment; somnolence less likely with oxybutynin transdermal patch; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • oxycodone
  • Reglan (metoclopramide)
    +
    oxycodone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + oxycodone

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • oxymorphone
  • Reglan (metoclopramide)
    +
    oxymorphone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + oxymorphone

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. oxymorphone start dose by at least 50%, consider decr. metoclopramide dose, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • paliperidone
  • Reglan (metoclopramide)
    +
    paliperidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + paliperidone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • paroxetine
  • Reglan (metoclopramide)
    +
    paroxetine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + paroxetine

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration; decr. metoclopramide dose: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, CNS depression, psychomotor impairment, serotonin syndrome, other adverse effects (hepatic metabolism inhibited, additive effects)

  • passion flower
  • Reglan (metoclopramide)
    +
    passion flower
    1 interaction

    Avoid/Use Alternative

    metoclopramide + passion flower

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • pentazocine
  • Reglan (metoclopramide)
    +
    pentazocine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pentazocine

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • pentobarbital
  • Reglan (metoclopramide)
    +
    pentobarbital
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pentobarbital

    use alternative or monitor respiratory rate: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • perampanel
  • Reglan (metoclopramide)
    +
    perampanel
    1 interaction

    Avoid/Use Alternative

    metoclopramide + perampanel

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • perphenazine
  • Reglan (metoclopramide)
    +
    perphenazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + perphenazine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • phenelzine
  • Reglan (metoclopramide)
    +
    phenelzine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + phenelzine

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN, including hypertensive crisis (additive effects)

  • pheniramine
  • Reglan (metoclopramide)
    +
    pheniramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pheniramine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • phenobarbital
  • Reglan (metoclopramide)
    +
    phenobarbital
    1 interaction

    Avoid/Use Alternative

    metoclopramide + phenobarbital

    use alternative or monitor respiratory rate: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression and respiratory depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • phenytoin
  • Reglan (metoclopramide)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + phenytoin

    use alternative: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • pimozide
  • Reglan (metoclopramide)
    +
    pimozide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pimozide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • pramipexole
  • Reglan (metoclopramide)
    +
    pramipexole
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pramipexole

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • pramlintide
  • Reglan (metoclopramide)
    +
    pramlintide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pramlintide

    consider alternative: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • pregabalin
  • Reglan (metoclopramide)
    +
    pregabalin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pregabalin

    use alternative or monitor respiratory rate: combo may alter seizure control; may incr. risk of profound CNS and respiratory depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • primaquine
  • Reglan (metoclopramide)
    +
    primaquine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + primaquine

    use alternative or monitor methemoglobin levels: combo may incr. risk of methemoglobinemia (additive effects)

  • primidone
  • Reglan (metoclopramide)
    +
    primidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + primidone

    use alternative or monitor respiratory rate: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, metoclopramide may decr. seizure threshold)

  • procarbazine
  • Reglan (metoclopramide)
    +
    procarbazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + procarbazine

    avoid combo: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • prochlorperazine
  • Reglan (metoclopramide)
    +
    prochlorperazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + prochlorperazine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • promethazine
  • Reglan (metoclopramide)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + promethazine

    avoid combo: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, extrapyramidal symptoms, seizures; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • propofol
  • Reglan (metoclopramide)
    +
    propofol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + propofol

    use alternative or monitor respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • protriptyline
  • Reglan (metoclopramide)
    +
    protriptyline
    1 interaction

    Avoid/Use Alternative

    metoclopramide + protriptyline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • pyrilamine
  • Reglan (metoclopramide)
    +
    pyrilamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + pyrilamine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • quazepam
  • Reglan (metoclopramide)
    +
    quazepam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + quazepam

    use alternative or monitor respiratory rate, consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • quetiapine
  • Reglan (metoclopramide)
    +
    quetiapine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + quetiapine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms, HTN; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • quinidine (antiarrhythmic)
  • Reglan (metoclopramide)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Avoid/Use Alternative

    metoclopramide + quinidine (antiarrhythmic)

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: decr. metoclopramide dose: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, other adverse effects (hepatic metabolism inhibited)

  • quinidine (CYP2D6 inhibitor)
  • Reglan (metoclopramide)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Avoid/Use Alternative

    metoclopramide + quinidine (CYP2D6 inhibitor)

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: decr. metoclopramide dose: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, other adverse effects (hepatic metabolism inhibited)

  • ramelteon
  • Reglan (metoclopramide)
    +
    ramelteon
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ramelteon

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rasagiline
  • Reglan (metoclopramide)
    +
    rasagiline
    1 interaction

    Avoid/Use Alternative

    metoclopramide + rasagiline

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN, including hypertensive crisis; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • remifentanil
  • Reglan (metoclopramide)
    +
    remifentanil
    1 interaction

    Avoid/Use Alternative

    metoclopramide + remifentanil

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • remimazolam
  • Reglan (metoclopramide)
    +
    remimazolam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + remimazolam

    use alternative or monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • repotrectinib
  • Reglan (metoclopramide)
    +
    repotrectinib
    1 interaction

    Avoid/Use Alternative

    metoclopramide + repotrectinib

    use alternative: combo may decr. metoclopramide levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • risperidone
  • Reglan (metoclopramide)
    +
    risperidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + risperidone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • rivastigmine
  • Reglan (metoclopramide)
    +
    rivastigmine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + rivastigmine

    avoid combo: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • rizatriptan
  • Reglan (metoclopramide)
    +
    rizatriptan
    1 interaction

    Avoid/Use Alternative

    metoclopramide + rizatriptan

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • ropeginterferon alfa-2b
  • Reglan (metoclopramide)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ropeginterferon alfa-2b

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ropinirole
  • Reglan (metoclopramide)
    +
    ropinirole
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ropinirole

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, HTN; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • rotigotine transdermal
  • Reglan (metoclopramide)
    +
    rotigotine transdermal
    1 interaction

    Avoid/Use Alternative

    metoclopramide + rotigotine transdermal

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, HTN; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • rufinamide
  • Reglan (metoclopramide)
    +
    rufinamide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + rufinamide

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • safinamide
  • Reglan (metoclopramide)
    +
    safinamide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + safinamide

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • scopolamine
  • Reglan (metoclopramide)
    +
    scopolamine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + scopolamine

    use alternative: combo may increase risk of CNS depression, psychomotor impairment; may decrease metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • selegiline
  • Reglan (metoclopramide)
    +
    selegiline
    1 interaction

    Avoid/Use Alternative

    metoclopramide + selegiline

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN, including hypertensive crisis; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • selegiline transdermal
  • Reglan (metoclopramide)
    +
    selegiline transdermal
    1 interaction

    Avoid/Use Alternative

    metoclopramide + selegiline transdermal

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN, including hypertensive crisis; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • selinexor
  • Reglan (metoclopramide)
    +
    selinexor
    1 interaction

    Avoid/Use Alternative

    metoclopramide + selinexor

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sertraline
  • Reglan (metoclopramide)
    +
    sertraline
    1 interaction

    Avoid/Use Alternative

    metoclopramide + sertraline

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome (additive effects)

  • sevoflurane
  • Reglan (metoclopramide)
    +
    sevoflurane
    1 interaction

    Avoid/Use Alternative

    metoclopramide + sevoflurane

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • solifenacin
  • Reglan (metoclopramide)
    +
    solifenacin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + solifenacin

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • solriamfetol
  • Reglan (metoclopramide)
    +
    solriamfetol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + solriamfetol

    avoid combo: combo may incr. risk of HTN; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • stiripentol
  • Reglan (metoclopramide)
    +
    stiripentol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + stiripentol

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • sufentanil
  • Reglan (metoclopramide)
    +
    sufentanil
    1 interaction

    Avoid/Use Alternative

    metoclopramide + sufentanil

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. sufentanil start dose, consider decr. metoclopramide dose, use lowest effective doses: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • sumatriptan
  • Reglan (metoclopramide)
    +
    sumatriptan
    1 interaction

    Avoid/Use Alternative

    metoclopramide + sumatriptan

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • suvorexant
  • Reglan (metoclopramide)
    +
    suvorexant
    1 interaction

    Avoid/Use Alternative

    metoclopramide + suvorexant

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tapentadol
  • Reglan (metoclopramide)
    +
    tapentadol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tapentadol

    use alternative or monitor respiratory rate, BP, serotonin syndrome symptoms, especially during initiation/titration; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension (including orthostasis, syncope), serotonin syndrome; may decrease metoclopramide efficacy (additive effects; antagonistic effects, absorption of oral metoclopramide affected by delayed gastric emptying)

  • tasimelteon
  • Reglan (metoclopramide)
    +
    tasimelteon
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tasimelteon

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tedizolid
  • Reglan (metoclopramide)
    +
    tedizolid
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tedizolid

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, tedizolid reversibly inhibits monoamine oxidase)

  • temazepam
  • Reglan (metoclopramide)
    +
    temazepam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + temazepam

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • terbinafine
  • Reglan (metoclopramide)
    +
    terbinafine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + terbinafine

    INJECTABLE OR NASAL METOCLOPRAMIDE: avoid combo; ORAL METOCLOPRAMIDE: decr. metoclopramide dose: combo may incr. metoclopramide levels, risk of extrapyramidal symptoms, other adverse effects (hepatic metabolism inhibited)

  • tetrabenazine
  • Reglan (metoclopramide)
    +
    tetrabenazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tetrabenazine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • thalidomide
  • Reglan (metoclopramide)
    +
    thalidomide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + thalidomide

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • thioridazine
  • Reglan (metoclopramide)
    +
    thioridazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + thioridazine

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • thiotepa
  • Reglan (metoclopramide)
    +
    thiotepa
    1 interaction

    Avoid/Use Alternative

    metoclopramide + thiotepa

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • thiothixene
  • Reglan (metoclopramide)
    +
    thiothixene
    1 interaction

    Avoid/Use Alternative

    metoclopramide + thiothixene

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • tiagabine
  • Reglan (metoclopramide)
    +
    tiagabine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tiagabine

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • tizanidine
  • Reglan (metoclopramide)
    +
    tizanidine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tizanidine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tolcapone
  • Reglan (metoclopramide)
    +
    tolcapone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tolcapone

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tolterodine
  • Reglan (metoclopramide)
    +
    tolterodine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tolterodine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • topiramate
  • Reglan (metoclopramide)
    +
    topiramate
    1 interaction

    Avoid/Use Alternative

    metoclopramide + topiramate

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • tradipitant
  • Reglan (metoclopramide)
    +
    tradipitant
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tradipitant

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tramadol
  • Reglan (metoclopramide)
    +
    tramadol
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tramadol

    use alternative or monitor respiratory rate, serotonin syndrome symptoms, especially during initiation/titration; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant use: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, serotonin syndrome, seizures; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • tranylcypromine
  • Reglan (metoclopramide)
    +
    tranylcypromine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + tranylcypromine

    avoid combo: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment, HTN, including hypertensive crisis (additive effects)

  • trazodone
  • Reglan (metoclopramide)
    +
    trazodone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + trazodone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • triazolam
  • Reglan (metoclopramide)
    +
    triazolam
    1 interaction

    Avoid/Use Alternative

    metoclopramide + triazolam

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • trifluoperazine
  • Reglan (metoclopramide)
    +
    trifluoperazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + trifluoperazine

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • trihexyphenidyl
  • Reglan (metoclopramide)
    +
    trihexyphenidyl
    1 interaction

    Avoid/Use Alternative

    metoclopramide + trihexyphenidyl

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • trimethobenzamide
  • Reglan (metoclopramide)
    +
    trimethobenzamide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + trimethobenzamide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • trimipramine
  • Reglan (metoclopramide)
    +
    trimipramine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + trimipramine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • triprolidine
  • Reglan (metoclopramide)
    +
    triprolidine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + triprolidine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • triptorelin
  • Reglan (metoclopramide)
    +
    triptorelin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + triptorelin

    avoid combo: combo may decr. triptorelin efficacy (metoclopramide may cause hyperprolactinemia, decr. GnRH receptors)

  • trospium
  • Reglan (metoclopramide)
    +
    trospium
    1 interaction

    Avoid/Use Alternative

    metoclopramide + trospium

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment; may decr. metoclopramide efficacy (additive effects; antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • valbenazine
  • Reglan (metoclopramide)
    +
    valbenazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + valbenazine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valerian
  • Reglan (metoclopramide)
    +
    valerian
    1 interaction

    Avoid/Use Alternative

    metoclopramide + valerian

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valproic acid
  • Reglan (metoclopramide)
    +
    valproic acid
    1 interaction

    Avoid/Use Alternative

    metoclopramide + valproic acid

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • venlafaxine
  • Reglan (metoclopramide)
    +
    venlafaxine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + venlafaxine

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment, dystonia (additive effects)

  • vigabatrin
  • Reglan (metoclopramide)
    +
    vigabatrin
    1 interaction

    Avoid/Use Alternative

    metoclopramide + vigabatrin

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • vilazodone
  • Reglan (metoclopramide)
    +
    vilazodone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + vilazodone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • viloxazine
  • Reglan (metoclopramide)
    +
    viloxazine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + viloxazine

    use alternative or monitor BP, HR: combo may incr. risk of HTN, tachycardia, CNS depression, psychomotor impairment (additive effects)

  • vortioxetine
  • Reglan (metoclopramide)
    +
    vortioxetine
    1 interaction

    Avoid/Use Alternative

    metoclopramide + vortioxetine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • yohimbe
  • Reglan (metoclopramide)
    +
    yohimbe
    1 interaction

    Avoid/Use Alternative

    metoclopramide + yohimbe

    avoid combo: combo may incr. risk of serotonin syndrome, HTN (additive effects, yohimbe inhibits monoamine oxidase)

  • zaleplon
  • Reglan (metoclopramide)
    +
    zaleplon
    1 interaction

    Avoid/Use Alternative

    metoclopramide + zaleplon

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ziconotide
  • Reglan (metoclopramide)
    +
    ziconotide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ziconotide

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ziprasidone
  • Reglan (metoclopramide)
    +
    ziprasidone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + ziprasidone

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, serotonin syndrome, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • zolmitriptan
  • Reglan (metoclopramide)
    +
    zolmitriptan
    1 interaction

    Avoid/Use Alternative

    metoclopramide + zolmitriptan

    use alternative or monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome, CNS depression, psychomotor impairment (additive effects)

  • zolpidem
  • Reglan (metoclopramide)
    +
    zolpidem
    1 interaction

    Avoid/Use Alternative

    metoclopramide + zolpidem

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zonisamide
  • Reglan (metoclopramide)
    +
    zonisamide
    1 interaction

    Avoid/Use Alternative

    metoclopramide + zonisamide

    use alternative: combo may alter seizure control; may incr. risk of CNS depression, psychomotor impairment (antagonistic effects, metoclopramide may decr. seizure threshold; additive effects)

  • zuranolone
  • Reglan (metoclopramide)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    metoclopramide + zuranolone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Monitor/Modify Tx

  • abiraterone acetate
  • Reglan (metoclopramide)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • acebutolol
  • Reglan (metoclopramide)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • albuterol
  • Reglan (metoclopramide)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + albuterol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • albuterol inhaled
  • Reglan (metoclopramide)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    metoclopramide + albuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aliskiren
  • Reglan (metoclopramide)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    metoclopramide + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amiloride
  • Reglan (metoclopramide)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    metoclopramide + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amlodipine
  • Reglan (metoclopramide)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • angiotensin II
  • Reglan (metoclopramide)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    metoclopramide + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprocitentan
  • Reglan (metoclopramide)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    metoclopramide + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Reglan (metoclopramide)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    metoclopramide + arformoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • armodafinil
  • Reglan (metoclopramide)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    metoclopramide + armodafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asciminib
  • Reglan (metoclopramide)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atenolol
  • Reglan (metoclopramide)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atogepant
  • Reglan (metoclopramide)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    metoclopramide + atogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atomoxetine
  • Reglan (metoclopramide)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + atomoxetine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine ophthalmic
  • Reglan (metoclopramide)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    metoclopramide + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • axitinib
  • Reglan (metoclopramide)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Reglan (metoclopramide)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    metoclopramide + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benazepril
  • Reglan (metoclopramide)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Reglan (metoclopramide)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + benzphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betamethasone
  • Reglan (metoclopramide)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + betamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • Reglan (metoclopramide)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Reglan (metoclopramide)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bismuth subsalicylate
  • Reglan (metoclopramide)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Reglan (metoclopramide)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • black cohosh
  • Reglan (metoclopramide)
    +
    black cohosh
    1 interaction

    Monitor/Modify Tx

    metoclopramide + black cohosh

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • brigatinib
  • Reglan (metoclopramide)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • budesonide
  • Reglan (metoclopramide)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bumetanide
  • Reglan (metoclopramide)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + bumetanide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cabozantinib
  • Reglan (metoclopramide)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Reglan (metoclopramide)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + caffeine

    monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

  • caffeine citrate
  • Reglan (metoclopramide)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + caffeine citrate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • candesartan cilexetil
  • Reglan (metoclopramide)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    metoclopramide + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • captopril
  • Reglan (metoclopramide)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • Reglan (metoclopramide)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + carfilzomib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • carvedilol
  • Reglan (metoclopramide)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • celecoxib
  • Reglan (metoclopramide)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • chlorothiazide
  • Reglan (metoclopramide)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + chlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorthalidone
  • Reglan (metoclopramide)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + chlorthalidone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clevidipine
  • Reglan (metoclopramide)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cocaine
  • Reglan (metoclopramide)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + cocaine

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN (additive effects)

  • copanlisib
  • Reglan (metoclopramide)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Reglan (metoclopramide)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + corticotropin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cortisone
  • Reglan (metoclopramide)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + cortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cyclosporine
  • Reglan (metoclopramide)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + cyclosporine

    monitor BP, cyclosporine levels, renal fxn: combo may incr. cyclosporine levels, risk of serious infection, nephrotoxicity, HTN, other adverse effects (absorption increased, additive effects)

  • danazol
  • Reglan (metoclopramide)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + danazol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • darbepoetin alfa
  • Reglan (metoclopramide)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    metoclopramide + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • deflazacort
  • Reglan (metoclopramide)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    metoclopramide + deflazacort

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desmopressin
  • Reglan (metoclopramide)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + desmopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Reglan (metoclopramide)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + dexamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexmethylphenidate
  • Reglan (metoclopramide)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + dexmethylphenidate

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN (additive effects)

  • dextromethorphan
  • Reglan (metoclopramide)
    +
    dextromethorphan
    1 interaction

    Monitor/Modify Tx

    metoclopramide + dextromethorphan

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • diclofenac
  • Reglan (metoclopramide)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    metoclopramide + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Reglan (metoclopramide)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    metoclopramide + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diethylpropion
  • Reglan (metoclopramide)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    metoclopramide + diethylpropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diflunisal
  • Reglan (metoclopramide)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    metoclopramide + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • digoxin
  • Reglan (metoclopramide)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + digoxin

    monitor digoxin levels, may need to incr. digoxin dose 20-40%: combo may decr. digoxin levels, efficacy (absorption delayed, decreased)

  • dihydroergotamine
  • Reglan (metoclopramide)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + dihydroergotamine

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of severe HTN, vasospasm, ischemia, serotonin syndrome (additive effects)

  • diltiazem
  • Reglan (metoclopramide)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    metoclopramide + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dobutamine
  • Reglan (metoclopramide)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dopamine
  • Reglan (metoclopramide)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • Reglan (metoclopramide)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    metoclopramide + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Reglan (metoclopramide)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • droxidopa
  • Reglan (metoclopramide)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    metoclopramide + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • enalapril
  • Reglan (metoclopramide)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Reglan (metoclopramide)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    metoclopramide + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedra
  • Reglan (metoclopramide)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ephedra

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine injection
  • Reglan (metoclopramide)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ephedrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine oral
  • Reglan (metoclopramide)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ephedrine oral

    monitor BP: combo may incr. risk of HTN (additive effects)

  • epinephrine
  • Reglan (metoclopramide)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + epinephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eplerenone
  • Reglan (metoclopramide)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Reglan (metoclopramide)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    metoclopramide + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eptinezumab
  • Reglan (metoclopramide)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • Reglan (metoclopramide)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Reglan (metoclopramide)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ergotamine

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of severe HTN, vasospasm, ischemia, serotonin syndrome (additive effects)

  • esmolol
  • Reglan (metoclopramide)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Reglan (metoclopramide)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    metoclopramide + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Reglan (metoclopramide)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    metoclopramide + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Reglan (metoclopramide)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ethacrynic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethinyl estradiol (contraceptive)
  • Reglan (metoclopramide)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Reglan (metoclopramide)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    metoclopramide + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Reglan (metoclopramide)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    metoclopramide + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • felodipine
  • Reglan (metoclopramide)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoldopam
  • Reglan (metoclopramide)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Reglan (metoclopramide)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Reglan (metoclopramide)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fludrocortisone
  • Reglan (metoclopramide)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fludrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flurbiprofen
  • Reglan (metoclopramide)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    metoclopramide + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flutamide
  • Reglan (metoclopramide)
    +
    flutamide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + flutamide

    consider monitoring methemoglobin levels: combo may incr. risk of methemoglobinemia (additive effects)

  • formoterol inhaled
  • Reglan (metoclopramide)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    metoclopramide + formoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fosinopril
  • Reglan (metoclopramide)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Reglan (metoclopramide)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fremanezumab
  • Reglan (metoclopramide)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Reglan (metoclopramide)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • galcanezumab
  • Reglan (metoclopramide)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hoodia
  • Reglan (metoclopramide)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    metoclopramide + hoodia

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydralazine
  • Reglan (metoclopramide)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Reglan (metoclopramide)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + hydrochlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Reglan (metoclopramide)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + hydrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxocobalamin IV
  • Reglan (metoclopramide)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    metoclopramide + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibrutinib
  • Reglan (metoclopramide)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Reglan (metoclopramide)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • indapamide
  • Reglan (metoclopramide)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + indapamide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • indomethacin
  • Reglan (metoclopramide)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • insulin
  • Reglan (metoclopramide)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + insulin

    monitor glucose: combo may incr. blood glucose, insulin requirements (possible increased dietary glucose absorption)

  • iopamidol
  • Reglan (metoclopramide)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + iopamidol

    caution advised if intrathecal iopamidol use; consider holding metoclopramide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • irbesartan
  • Reglan (metoclopramide)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    metoclopramide + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isradipine
  • Reglan (metoclopramide)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketoprofen
  • Reglan (metoclopramide)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Reglan (metoclopramide)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Reglan (metoclopramide)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Reglan (metoclopramide)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • leflunomide
  • Reglan (metoclopramide)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenvatinib
  • Reglan (metoclopramide)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levalbuterol inhaled
  • Reglan (metoclopramide)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    metoclopramide + levalbuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • licorice
  • Reglan (metoclopramide)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    metoclopramide + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lisinopril
  • Reglan (metoclopramide)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lorlatinib
  • Reglan (metoclopramide)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + lorlatinib

    monitor BP: combo may decr. metoclopramide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • losartan
  • Reglan (metoclopramide)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    metoclopramide + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Reglan (metoclopramide)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    metoclopramide + lumacaftor/ ivacaftor

    monitor BP: combo may decr. metoclopramide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • luspatercept
  • Reglan (metoclopramide)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    metoclopramide + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium salicylate
  • Reglan (metoclopramide)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • meclofenamate
  • Reglan (metoclopramide)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Reglan (metoclopramide)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    metoclopramide + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Reglan (metoclopramide)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    metoclopramide + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Reglan (metoclopramide)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    metoclopramide + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methylene blue injection
  • Reglan (metoclopramide)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    metoclopramide + methylene blue injection

    hold metoclopramide if emergency use; monitor serotonin syndrome sx up to 4h after last methylene blue dose; may resume metoclopramide 72h after last methylene blue dose: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • methylergonovine
  • Reglan (metoclopramide)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + methylergonovine

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of severe HTN, vasospasm, ischemia, serotonin syndrome (additive effects)

  • methylphenidate
  • Reglan (metoclopramide)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + methylphenidate

    monitor BP, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN (additive effects)

  • methylprednisolone
  • Reglan (metoclopramide)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + methylprednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Reglan (metoclopramide)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Reglan (metoclopramide)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + metolazone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoprolol
  • Reglan (metoclopramide)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • minoxidil
  • Reglan (metoclopramide)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    metoclopramide + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Reglan (metoclopramide)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    metoclopramide + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • modafinil
  • Reglan (metoclopramide)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    metoclopramide + modafinil

    monitor BP: combo may decr. metoclopramide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • moexipril
  • Reglan (metoclopramide)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nabumetone
  • Reglan (metoclopramide)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Reglan (metoclopramide)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Reglan (metoclopramide)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    metoclopramide + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naxitamab
  • Reglan (metoclopramide)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Reglan (metoclopramide)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicardipine
  • Reglan (metoclopramide)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nifedipine
  • Reglan (metoclopramide)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nimodipine
  • Reglan (metoclopramide)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Reglan (metoclopramide)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Reglan (metoclopramide)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nitric oxide
  • Reglan (metoclopramide)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nitric oxide

    monitor methemoglobin levels: combo may incr. risk of methemoglobinemia (additive effects)

  • nitrite
  • Reglan (metoclopramide)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    metoclopramide + nitrite

    monitor methemoglobin levels: combo may incr. risk of methemoglobinemia (additive effects)

  • norepinephrine
  • Reglan (metoclopramide)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • obinutuzumab
  • Reglan (metoclopramide)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Reglan (metoclopramide)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    metoclopramide + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Reglan (metoclopramide)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    metoclopramide + olodaterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • osilodrostat
  • Reglan (metoclopramide)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    metoclopramide + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxaprozin
  • Reglan (metoclopramide)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Reglan (metoclopramide)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    metoclopramide + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Reglan (metoclopramide)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Reglan (metoclopramide)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ozanimod

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • palonosetron
  • Reglan (metoclopramide)
    +
    palonosetron
    1 interaction

    Monitor/Modify Tx

    metoclopramide + palonosetron

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • pazopanib
  • Reglan (metoclopramide)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Reglan (metoclopramide)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Reglan (metoclopramide)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + pexidartinib

    monitor BP: combo may decr. metoclopramide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • phendimetrazine
  • Reglan (metoclopramide)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phendimetrazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • Reglan (metoclopramide)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Reglan (metoclopramide)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phentermine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phentolamine
  • Reglan (metoclopramide)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Reglan (metoclopramide)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phenylephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine injection
  • Reglan (metoclopramide)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Reglan (metoclopramide)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Reglan (metoclopramide)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN (additive effects)

  • phenylephrine rectal
  • Reglan (metoclopramide)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    metoclopramide + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pindolol
  • Reglan (metoclopramide)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • piroxicam
  • Reglan (metoclopramide)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    metoclopramide + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponatinib
  • Reglan (metoclopramide)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Reglan (metoclopramide)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • posaconazole
  • Reglan (metoclopramide)
    +
    posaconazole
    1 interaction

    Monitor/Modify Tx

    metoclopramide + posaconazole

    monitor breakthrough fungal infections w/ posaconazole IR oral suspension: combo may decr. posaconazole levels, efficacy (oral suspension absorption decreased)

  • pralsetinib
  • Reglan (metoclopramide)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prazosin
  • Reglan (metoclopramide)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Reglan (metoclopramide)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + prednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prednisone
  • Reglan (metoclopramide)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + prednisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • propranolol
  • Reglan (metoclopramide)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pseudoephedrine
  • Reglan (metoclopramide)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + pseudoephedrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Reglan (metoclopramide)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramipril
  • Reglan (metoclopramide)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Reglan (metoclopramide)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • regorafenib
  • Reglan (metoclopramide)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rimegepant
  • Reglan (metoclopramide)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    metoclopramide + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Reglan (metoclopramide)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salmeterol inhaled
  • Reglan (metoclopramide)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    metoclopramide + salmeterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salsalate
  • Reglan (metoclopramide)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    metoclopramide + salsalate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • SAMe
  • Reglan (metoclopramide)
    +
    SAMe
    1 interaction

    Monitor/Modify Tx

    metoclopramide + SAMe

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • selpercatinib
  • Reglan (metoclopramide)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • siponimod
  • Reglan (metoclopramide)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    metoclopramide + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sirolimus
  • Reglan (metoclopramide)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    metoclopramide + sirolimus

    monitor sirolimus levels: combo may incr. sirolimus levels, risk of serious infection, other adverse effects (absorption increased)

  • sorafenib
  • Reglan (metoclopramide)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Reglan (metoclopramide)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • St. John's wort
  • Reglan (metoclopramide)
    +
    St. John's wort
    1 interaction

    Monitor/Modify Tx

    metoclopramide + St. John's wort

    monitor serotonin syndrome sx, especially during initiation/titration: combo may decr. metoclopramide levels, efficacy; may incr. risk of serotonin syndrome (hepatic metabolism induced; additive effects)

  • succinylcholine
  • Reglan (metoclopramide)
    +
    succinylcholine
    1 interaction

    Monitor/Modify Tx

    metoclopramide + succinylcholine

    monitor respiratory rate: combo may incr. risk of respiratory depression, potentiate, prolong neuromuscular blockade (succinylcholine metabolism decreased; plasma cholinesterase inhibited)

  • sulindac
  • Reglan (metoclopramide)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    metoclopramide + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Reglan (metoclopramide)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Reglan (metoclopramide)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    metoclopramide + tacrolimus

    monitor oral tacrolimus levels, ECG, BP, renal fxn: combo may incr. tacrolimus levels, risk of QT prolongation, cardiac arrhythmias, HTN, nephrotoxicity, other adverse effects (absorption increased, additive effects)

  • tagraxofusp
  • Reglan (metoclopramide)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    metoclopramide + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Reglan (metoclopramide)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    metoclopramide + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Reglan (metoclopramide)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Reglan (metoclopramide)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    metoclopramide + terbutaline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • teriflunomide
  • Reglan (metoclopramide)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Reglan (metoclopramide)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • timolol
  • Reglan (metoclopramide)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    metoclopramide + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tivozanib
  • Reglan (metoclopramide)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Reglan (metoclopramide)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • torsemide
  • Reglan (metoclopramide)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    metoclopramide + torsemide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trametinib
  • Reglan (metoclopramide)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Reglan (metoclopramide)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    metoclopramide + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Reglan (metoclopramide)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + triamcinolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • triamterene
  • Reglan (metoclopramide)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    metoclopramide + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ubrogepant
  • Reglan (metoclopramide)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ubrogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vadadustat
  • Reglan (metoclopramide)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    metoclopramide + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Reglan (metoclopramide)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    metoclopramide + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Reglan (metoclopramide)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    metoclopramide + vamorolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vandetanib
  • Reglan (metoclopramide)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    metoclopramide + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Reglan (metoclopramide)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Reglan (metoclopramide)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    metoclopramide + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Reglan (metoclopramide)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    metoclopramide + vilanterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • voclosporin
  • Reglan (metoclopramide)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    metoclopramide + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zavegepant
  • Reglan (metoclopramide)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    metoclopramide + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Reglan (metoclopramide)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    metoclopramide + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

Caution Advised

  • acetazolamide
  • Reglan (metoclopramide)
    +
    acetazolamide
    1 interaction

    Caution Advised

    metoclopramide + acetazolamide

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, metoclopramide may decr. seizure threshold)

  • aclidinium inhaled
  • Reglan (metoclopramide)
    +
    aclidinium inhaled
    1 interaction

    Caution Advised

    metoclopramide + aclidinium inhaled

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • apalutamide
  • Reglan (metoclopramide)
    +
    apalutamide
    1 interaction

    Caution Advised

    metoclopramide + apalutamide

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • articaine
  • Reglan (metoclopramide)
    +
    articaine
    1 interaction

    Caution Advised

    metoclopramide + articaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • atropine
  • Reglan (metoclopramide)
    +
    atropine
    1 interaction

    Caution Advised

    metoclopramide + atropine

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • belladonna alkaloids
  • Reglan (metoclopramide)
    +
    belladonna alkaloids
    1 interaction

    Caution Advised

    metoclopramide + belladonna alkaloids

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • benzocaine topical
  • Reglan (metoclopramide)
    +
    benzocaine topical
    1 interaction

    Caution Advised

    metoclopramide + benzocaine topical

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • benztropine
  • Reglan (metoclopramide)
    +
    benztropine
    1 interaction

    Caution Advised

    metoclopramide + benztropine

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • bosentan
  • Reglan (metoclopramide)
    +
    bosentan
    1 interaction

    Caution Advised

    metoclopramide + bosentan

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • bremelanotide
  • Reglan (metoclopramide)
    +
    bremelanotide
    1 interaction

    Caution Advised

    metoclopramide + bremelanotide

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • bupivacaine
  • Reglan (metoclopramide)
    +
    bupivacaine
    1 interaction

    Caution Advised

    metoclopramide + bupivacaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • bupivacaine liposomal
  • Reglan (metoclopramide)
    +
    bupivacaine liposomal
    1 interaction

    Caution Advised

    metoclopramide + bupivacaine liposomal

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • busulfan
  • Reglan (metoclopramide)
    +
    busulfan
    1 interaction

    Caution Advised

    metoclopramide + busulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • butamben
  • Reglan (metoclopramide)
    +
    butamben
    1 interaction

    Caution Advised

    metoclopramide + butamben

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • chlorambucil
  • Reglan (metoclopramide)
    +
    chlorambucil
    1 interaction

    Caution Advised

    metoclopramide + chlorambucil

    caution advised: combo may incr. risk of seizures (additive effects)

  • chloroprocaine
  • Reglan (metoclopramide)
    +
    chloroprocaine
    1 interaction

    Caution Advised

    metoclopramide + chloroprocaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • clidinium
  • Reglan (metoclopramide)
    +
    clidinium
    1 interaction

    Caution Advised

    metoclopramide + clidinium

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • dabrafenib
  • Reglan (metoclopramide)
    +
    dabrafenib
    1 interaction

    Caution Advised

    metoclopramide + dabrafenib

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • dapsone
  • Reglan (metoclopramide)
    +
    dapsone
    1 interaction

    Caution Advised

    metoclopramide + dapsone

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • dapsone topical
  • Reglan (metoclopramide)
    +
    dapsone topical
    1 interaction

    Caution Advised

    metoclopramide + dapsone topical

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • dicyclomine
  • Reglan (metoclopramide)
    +
    dicyclomine
    1 interaction

    Caution Advised

    metoclopramide + dicyclomine

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • disopyramide
  • Reglan (metoclopramide)
    +
    disopyramide
    1 interaction

    Caution Advised

    metoclopramide + disopyramide

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • dulaglutide
  • Reglan (metoclopramide)
    +
    dulaglutide
    1 interaction

    Caution Advised

    metoclopramide + dulaglutide

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • encorafenib
  • Reglan (metoclopramide)
    +
    encorafenib
    1 interaction

    Caution Advised

    metoclopramide + encorafenib

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • Reglan (metoclopramide)
    +
    enzalutamide
    1 interaction

    Caution Advised

    metoclopramide + enzalutamide

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • etravirine
  • Reglan (metoclopramide)
    +
    etravirine
    1 interaction

    Caution Advised

    metoclopramide + etravirine

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • exenatide
  • Reglan (metoclopramide)
    +
    exenatide
    1 interaction

    Caution Advised

    metoclopramide + exenatide

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • fexinidazole
  • Reglan (metoclopramide)
    +
    fexinidazole
    1 interaction

    Caution Advised

    metoclopramide + fexinidazole

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • flavoxate
  • Reglan (metoclopramide)
    +
    flavoxate
    1 interaction

    Caution Advised

    metoclopramide + flavoxate

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • fosfomycin oral
  • Reglan (metoclopramide)
    +
    fosfomycin oral
    1 interaction

    Caution Advised

    metoclopramide + fosfomycin oral

    caution advised: combo may decr. fosfomycin levels, efficacy (absorption decreased)

  • glycopyrrolate inhaled
  • Reglan (metoclopramide)
    +
    glycopyrrolate inhaled
    1 interaction

    Caution Advised

    metoclopramide + glycopyrrolate inhaled

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • glycopyrronium topical
  • Reglan (metoclopramide)
    +
    glycopyrronium topical
    1 interaction

    Caution Advised

    metoclopramide + glycopyrronium topical

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • goserelin
  • Reglan (metoclopramide)
    +
    goserelin
    1 interaction

    Caution Advised

    metoclopramide + goserelin

    caution advised: combo may decr. goserelin efficacy (metoclopramide may cause hyperprolactinemia, decr. GnRH receptors)

  • histrelin
  • Reglan (metoclopramide)
    +
    histrelin
    1 interaction

    Caution Advised

    metoclopramide + histrelin

    caution advised: combo may decr. histrelin efficacy (metoclopramide may cause hyperprolactinemia, decr. GnRH receptors)

  • homatropine
  • Reglan (metoclopramide)
    +
    homatropine
    1 interaction

    Caution Advised

    metoclopramide + homatropine

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • hydroxychloroquine
  • Reglan (metoclopramide)
    +
    hydroxychloroquine
    1 interaction

    Caution Advised

    metoclopramide + hydroxychloroquine

    caution advised: combo may incr. risk of seizures (additive effects)

  • ipratropium inhaled
  • Reglan (metoclopramide)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    metoclopramide + ipratropium inhaled

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • isosorbide dinitrate
  • Reglan (metoclopramide)
    +
    isosorbide dinitrate
    1 interaction

    Caution Advised

    metoclopramide + isosorbide dinitrate

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • isosorbide mononitrate
  • Reglan (metoclopramide)
    +
    isosorbide mononitrate
    1 interaction

    Caution Advised

    metoclopramide + isosorbide mononitrate

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • ivosidenib
  • Reglan (metoclopramide)
    +
    ivosidenib
    1 interaction

    Caution Advised

    metoclopramide + ivosidenib

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • leuprolide
  • Reglan (metoclopramide)
    +
    leuprolide
    1 interaction

    Caution Advised

    metoclopramide + leuprolide

    caution advised: combo may decr. leuprolide efficacy (metoclopramide may cause hyperprolactinemia, decr. GnRH receptors)

  • lidocaine
  • Reglan (metoclopramide)
    +
    lidocaine
    1 interaction

    Caution Advised

    metoclopramide + lidocaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • liraglutide
  • Reglan (metoclopramide)
    +
    liraglutide
    1 interaction

    Caution Advised

    metoclopramide + liraglutide

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • lixisenatide
  • Reglan (metoclopramide)
    +
    lixisenatide
    1 interaction

    Caution Advised

    metoclopramide + lixisenatide

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • loperamide
  • Reglan (metoclopramide)
    +
    loperamide
    1 interaction

    Caution Advised

    metoclopramide + loperamide

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • lopinavir/ritonavir
  • Reglan (metoclopramide)
    +
    lopinavir/ ritonavir
    1 interaction

    Caution Advised

    metoclopramide + lopinavir/ ritonavir

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • magnesium citrate
  • Reglan (metoclopramide)
    +
    magnesium citrate
    1 interaction

    Caution Advised

    metoclopramide + magnesium citrate

    caution advised, especially if magnesium citrate bowel prep use: combo may incr. risk of seizures (additive effects)

  • mavacamten
  • Reglan (metoclopramide)
    +
    mavacamten
    1 interaction

    Caution Advised

    metoclopramide + mavacamten

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • mepivacaine
  • Reglan (metoclopramide)
    +
    mepivacaine
    1 interaction

    Caution Advised

    metoclopramide + mepivacaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • methscopolamine
  • Reglan (metoclopramide)
    +
    methscopolamine
    1 interaction

    Caution Advised

    metoclopramide + methscopolamine

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • mexiletine
  • Reglan (metoclopramide)
    +
    mexiletine
    1 interaction

    Caution Advised

    metoclopramide + mexiletine

    caution advised: combo may incr. peak mexiletine levels, risk of adverse effects (absorption increased)

  • mitapivat
  • Reglan (metoclopramide)
    +
    mitapivat
    1 interaction

    Caution Advised

    metoclopramide + mitapivat

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • nafcillin
  • Reglan (metoclopramide)
    +
    nafcillin
    1 interaction

    Caution Advised

    metoclopramide + nafcillin

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • nitrofurantoin
  • Reglan (metoclopramide)
    +
    nitrofurantoin
    1 interaction

    Caution Advised

    metoclopramide + nitrofurantoin

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • nitroglycerin
  • Reglan (metoclopramide)
    +
    nitroglycerin
    1 interaction

    Caution Advised

    metoclopramide + nitroglycerin

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • nitroprusside
  • Reglan (metoclopramide)
    +
    nitroprusside
    1 interaction

    Caution Advised

    metoclopramide + nitroprusside

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • pacritinib
  • Reglan (metoclopramide)
    +
    pacritinib
    1 interaction

    Caution Advised

    metoclopramide + pacritinib

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • polyethylene glycol
  • Reglan (metoclopramide)
    +
    polyethylene glycol
    1 interaction

    Caution Advised

    metoclopramide + polyethylene glycol

    caution advised, especially if polyethylene glycol bowel prep use: combo may incr. risk of seizures (additive effects)

  • polyethylene glycol/electrolytes
  • Reglan (metoclopramide)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Caution Advised

    metoclopramide + polyethylene glycol/ electrolytes

    caution advised: combo may incr. risk of seizures (additive effects)

  • procaine
  • Reglan (metoclopramide)
    +
    procaine
    1 interaction

    Caution Advised

    metoclopramide + procaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • rasburicase
  • Reglan (metoclopramide)
    +
    rasburicase
    1 interaction

    Caution Advised

    metoclopramide + rasburicase

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • resorcinol topical
  • Reglan (metoclopramide)
    +
    resorcinol topical
    1 interaction

    Caution Advised

    metoclopramide + resorcinol topical

    caution advised, especially w/ prolonged and/or high dose resorcinol tx: combo may incr. risk of methemoglobinemia (additive effects)

  • revefenacin inhaled
  • Reglan (metoclopramide)
    +
    revefenacin inhaled
    1 interaction

    Caution Advised

    metoclopramide + revefenacin inhaled

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • rifabutin
  • Reglan (metoclopramide)
    +
    rifabutin
    1 interaction

    Caution Advised

    metoclopramide + rifabutin

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • rifampin
  • Reglan (metoclopramide)
    +
    rifampin
    1 interaction

    Caution Advised

    metoclopramide + rifampin

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • rifapentine
  • Reglan (metoclopramide)
    +
    rifapentine
    1 interaction

    Caution Advised

    metoclopramide + rifapentine

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • ropivacaine
  • Reglan (metoclopramide)
    +
    ropivacaine
    1 interaction

    Caution Advised

    metoclopramide + ropivacaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • sodium picosulfate
  • Reglan (metoclopramide)
    +
    sodium picosulfate
    1 interaction

    Caution Advised

    metoclopramide + sodium picosulfate

    caution advised: combo may incr. risk of seizures (additive effects)

  • sofpironium topical
  • Reglan (metoclopramide)
    +
    sofpironium topical
    1 interaction

    Caution Advised

    metoclopramide + sofpironium topical

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • sotorasib
  • Reglan (metoclopramide)
    +
    sotorasib
    1 interaction

    Caution Advised

    metoclopramide + sotorasib

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • sulfadiazine
  • Reglan (metoclopramide)
    +
    sulfadiazine
    1 interaction

    Caution Advised

    metoclopramide + sulfadiazine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • sulfamethoxazole
  • Reglan (metoclopramide)
    +
    sulfamethoxazole
    1 interaction

    Caution Advised

    metoclopramide + sulfamethoxazole

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • sulfasalazine
  • Reglan (metoclopramide)
    +
    sulfasalazine
    1 interaction

    Caution Advised

    metoclopramide + sulfasalazine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • sulfate bowel prep
  • Reglan (metoclopramide)
    +
    sulfate bowel prep
    1 interaction

    Caution Advised

    metoclopramide + sulfate bowel prep

    caution advised: combo may incr. risk of seizures (additive effects)

  • tafenoquine
  • Reglan (metoclopramide)
    +
    tafenoquine
    1 interaction

    Caution Advised

    metoclopramide + tafenoquine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • tetracaine
  • Reglan (metoclopramide)
    +
    tetracaine
    1 interaction

    Caution Advised

    metoclopramide + tetracaine

    caution advised: combo may incr. risk of methemoglobinemia (additive effects)

  • tiotropium inhaled
  • Reglan (metoclopramide)
    +
    tiotropium inhaled
    1 interaction

    Caution Advised

    metoclopramide + tiotropium inhaled

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • tirzepatide
  • Reglan (metoclopramide)
    +
    tirzepatide
    1 interaction

    Caution Advised

    metoclopramide + tirzepatide

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

  • treosulfan
  • Reglan (metoclopramide)
    +
    treosulfan
    1 interaction

    Caution Advised

    metoclopramide + treosulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • umeclidinium inhaled
  • Reglan (metoclopramide)
    +
    umeclidinium inhaled
    1 interaction

    Caution Advised

    metoclopramide + umeclidinium inhaled

    caution advised: combo may decr. metoclopramide efficacy (antagonistic effects; absorption of oral metoclopramide affected by delayed gastric emptying)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@7252c9e1
  • extrapyramidal symptoms
  • dystonia, acute
  • parkinsonism
  • tardive dyskinesia
  • neuroleptic malignant syndrome
  • seizures
  • depression
  • suicidality
  • hallucinations
  • leukopenia
  • neutropenia
  • agranulocytosis
  • methemoglobinemia
  • CHF, acute
  • AV block
  • SVT
  • HTN, severe
  • angioedema
  • hepatotoxicity
  • withdrawal symptoms if abrupt D/C

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@27da67d
  • drowsiness
  • restlessness
  • fatigue
  • anxiety
  • insomnia
  • headache
  • confusion
  • dizziness
  • depression
  • extrapyramidal symptoms
  • galactorrhea
  • amenorrhea
  • gynecomastia
  • hyperprolactinemia
  • impotence
  • hyperaldosteronism
  • fluid retention
  • hypotension
  • HTN
  • bradycardia
  • nausea
  • diarrhea
  • urinary frequency
  • incontinence
  • rash
  • urticaria
  • visual disturbance

Safety/Monitoring .

Monitoring Parameters
Cr at baseline; signs/symptoms of tardive dyskinesia routinely if >12wk tx

Look/Sound-Alike Drug Names
Reglan confused with: Megace; Regitine; Regonol; Relafen; Renagel; Requip; Robaxin; Robitussin; Zofran


metoclopramide confused with: methocarbamol; methylPREDNISolone sodium succinate; metOLazone; metoprolol; metoprolol tartrate; metroNIDAZOLE; trimethobenzamide

Pregnancy/Lactation .

Pregnancy

Clinical Summary

may use during pregnancy; no known risk of fetal harm based on human data

Lactation

Clinical Summary

may use while breastfeeding; no known risk of infant harm or adverse effects on milk production based on human data

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@6b4e167a

Metabolism: for metoclopramide: liver minimally; CYP450: 2D6 substrate

Excretion: for metoclopramide: urine 85% (20% unchanged), bile/feces 5%; Half-life: 5-6h

Subclass: Antiemetics, Dopamine Antagonists ; Diagnostic Agents, Gastrointestinal ; Headache/Migraine ; Prokinetics

Mechanism of Action
for metoclopramide: exact mechanism of action unknown; sensitizes tissues to acetylcholine, stimulating upper GI tract motility; antagonizes central and peripheral dopamine receptors, producing antiemetic effects

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: ANI Pharmaceuticals, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@27b3b5c9

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet:

  • 5 mg (1 ea): $7.00
  • 10 mg (1 ea): $7.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information